Literature DB >> 160896

Suppression of T cell-mediated immunity by tumor cells: immunogenicity versus immunosuppression and preliminary characterization of the suppressive factors.

C C Ting, D Rodrigues, R C Ting, N Wivel, M J Collins.   

Abstract

In studying the immunogenicity of spleen cells and tumor cells in the generation, of cytotoxic T lymphocyte (CTL) in the allogeneic mixed lymphocyte culture (MLC) or mixed lymphocyte tumor cell culture (MLTC) reactions, we have found that the tumor cells not only appear to be poorly immunogenic, but are also immunosuppressive. This was shown by the ability of the tumor cells or their cell-free extracts to suppress standard MLC reactions. This suppression was acting mainly at the induction phase of the cytotoxic response. It could not interfere with the killing activity of the fully generated CTLs. In a Friend virus-induced leukemia FBL-3 system, at least two major components could be attributed to the cause of immunosuppression; one was of viral origin and the other was of non-viral origin. The viral component was sensitive to UV-irradiation and could be pelleted after ultracentrifugation at 100,000 g. The non-viral component was UV-resistant and was retained in the supernatant fraction after ultracentrifugation. Friend virus and 12 commonly found murine viruses have been excluded as the possible candidates causing the immunosuppression. The immunosuppressive viruses are very likely of endogenous origin and are defective in replication as shown by electromicroscopy, and by the virus focus-inducing and reverse transcriptase assays. These findings indicate that probably all tumor cells possess the immunosuppressive factor(s) which may account for their apparent lack of immunogenicity and the lack of proper immune responses in the tumor-bearing hosts.

Entities:  

Mesh:

Year:  1979        PMID: 160896     DOI: 10.1002/ijc.2910240519

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Switching on the macrophage-mediated suppressor mechanism by tumor cells to evade host immune surveillance.

Authors:  C C Ting; D Rodrigues
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

2.  The immune response to a chemically induced fibrosarcoma: a comparison of cytolytic T lymphocyte stimulation by transformed and non-transformed fibroblasts.

Authors:  T L Bowlin; M R Proffitt
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

3.  Lung cancer with gastrointestinal metastasis - review of theories of metastasis with three rare case descriptions.

Authors:  Rohtesh S Mehta; Andrew D Liman; Vida A Passero; Agnes K Liman
Journal:  Cancer Microenviron       Date:  2013-08-21

4.  Immunosuppression in murine renal cell carcinoma. II. Identification of responsible lymphoid cell phenotypes and examination of elimination of suppression.

Authors:  S K Gregorian; J R Battisto
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

5.  Suppression of cytotoxic T lymphocyte activity by gamma/delta T cells in tumor-bearing mice.

Authors:  N Seo; K Egawa
Journal:  Cancer Immunol Immunother       Date:  1995-06       Impact factor: 6.968

6.  The clinical study on treatment of CD19-directed chimeric antigen receptor-modified T cells in a case of refractory Richter syndrome.

Authors:  Leiming Xia; Yi Wang; Tan Li; Xueying Hu; Qian Chen; Liu Liu; Beilei Jiang; Caixin Li; Hua Wang; Siying Wang; Guanghua Yang; Yangyi Bao
Journal:  Cancer Med       Date:  2019-05-02       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.